Skip to main content

Table 2 Univariable and multivariable conditional logistic regression analysis regarding risk of infection with ESBL-producing pathogen (vs. non-ESBL)

From: Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018

 

Univariate

OR [95%-CI] (p value)

Multivariable

aOR [95%-CI] (p value)

Male versus female

2.4 [1.0–5.4] (0.04)

2.3 [0.9–5.0] (0.08)

Age (years) at time of infection

1.0 [0.9–1.0] (0.58)

0.9 [0.9–1.0] (0.99)

BMI at transplantation

1.0 [0.9–1.1] (0.92)

 

Caucasian versus others

0.4 [0.1–2.1] (0.27)

 

Comorbidities (yes/no)

 Cardiopulmonary disease

1.1 [0.6–2.3] (0.72)

 

 Metabolic/endocrine disease

0.5 [0.2–1.1] (0.10)

0.4 [0.2–1.1] (0.09)

 Cancer

1.4 [0.4–4.4] (0.57)

 

 Other

1.1 [0.5–2.7] (0.82)

 

Year of infection

 2012

 

 2013

1.2 [0.3–4.7] (0.83)

 

 2014

1.6 [0.3–7.1] (0.57)

 

 2015

2.5 [0.6–11.1] (0.23)

 

 2016

0.9 [0.2–5.3] (0.94)

 

Antibiotics (yes/no) before infectiona

2.4 [1.0–5.9] (0.048)

2.6 [1.0–6.8] (0.046)

  1. ESBL extended-spectrum beta-lactamase, (a)OR (adjusted) odds ratio, CI confidence interval, BMI body mass index
  2. aAny therapeutic or prophylactic antibiotic treatment within 30 days prior to infection